Modus Therapeutics will present new research findings on its investigational drug sevuparin for chronic kidney disease (CKD) with anemia...
Read MoreBradford-based Regal Foods has added another well-loved brand to its extensive food and drink empire, acquiring soft drinks producer...
Read MoreThe European Commission has approved ROMVIMZA (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumour...
Read MorePMV Pharmaceuticals has announced encouraging interim findings from the phase 2 portion of its PYNNACLE trial, which is evaluating...
Read MoreThe cola wars are entering a new phase – one where taste meets gut health. PepsiCo has announced the...
Read MoreLundbeck has presented compelling new clinical data on its migraine therapy eptinezumab at the 2025 International Headache Congress (IHC)...
Read More